Company Name: |
ChemStrong Scientific Co.,Ltd
|
Tel: |
0755-0755-66853366 13670046396 |
Email: |
sales@chem-strong.com |
Products Intro: |
Product Name:ArforMoterol Tartrate Impurity 1 CAS:245759-62-0 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
Company Name: |
Shanghai Kewel Chemical Co., Ltd.
|
Tel: |
021-64609169 18901607656 |
Email: |
greensnown@163.com |
Products Intro: |
Product Name:Formoterol Impurity 18 CAS:245759-62-0 Purity:95+ HPLC; Package:10mg;25mg;50mg;100mg
|
|
| (αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol Basic information |
Product Name: | (αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol | Synonyms: | (αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol;Formoterol Impurity 7;Benzenemethanol, 3-amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]-, (αR)-;Formoterol Impurity 18;ArforMoterol Tartrate Impurity 1;2-Amino-4-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenol;(αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol;Formoterol Impurity 50 | CAS: | 245759-62-0 | MF: | C18H24N2O3 | MW: | 316.4 | EINECS: | | Product Categories: | | Mol File: | 245759-62-0.mol | ![(αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol Structure](CAS/20210111/GIF/245759-62-0.gif) |
| (αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol Chemical Properties |
Boiling point | 545.7±50.0 °C(Predicted) | density | 1.195±0.06 g/cm3(Predicted) | pka | 9.81±0.31(Predicted) |
| (αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol Usage And Synthesis |
Uses | (αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol, is an impurity of Arformoterol Tartrate (A767505) which is a long-acting β2 adrenoreceptor agonist (LABA) indicated for the treatment of chronic obstructive pulmonary disease (COPD). |
| (αR)-3-Amino-4-hydroxy-α-[[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]methyl]benzenemethanol Preparation Products And Raw materials |
|